Summary
Professor Cross is a cancer epidemiologist in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group (http://csprg.org.uk) in the Department of Surgery and Cancer at Imperial.
She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut. Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.
Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk.
Publications
Journals
Pham TT, Nimptsch K, Aleksandrova K, et al., 2024, Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition study, International Journal of Cancer, Vol:154, ISSN:0020-7136, Pages:1596-1606
NCD Risk Factor Collaboration (NCD-RisC), 2024, Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults., Lancet, Vol:403, Pages:1027-1050
Mandle HB, Jenab M, Gunter MJ, et al., 2024, Inflammation and gut barrier function-related genes and colorectal cancer risk in Western European populations, Mutagenesis, ISSN:0267-8357
Harewood R, Rothwell JA, Bešević J, et al., 2024, Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC)., Ebiomedicine, Vol:101
Murphy G, Freedman ND, Abnet CC, et al., 2024, Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO, Helicobacter (oxford), Vol:29, ISSN:1083-4389